Meridian Wealth Partners’s Bausch Health BHC Stock Holding History

Meridian Wealth Partners’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-403	Closed	-$12K	–	227
2021 Q1	$12K	Buy	+403	New	+$11.8K	﹤0.01%	396

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Meridian Wealth Partners's BHC Position: Q2 2021 in Review

Meridian Wealth Partners sold out of Bausch Health (BHC) in Q2 2021, closing a stake of 403 shares — an estimated $12K sold.

Meridian Wealth Partners first reported a position in BHC in Q1 2021 and held it in 1 quarter. The position peaked at $12K in Q1 2021. 357 funds tracked by Wall St. Rank hold BHC as of Q2 2021.

Meridian Wealth Partners reported no remaining Bausch Health position as of Q2 2021 after selling out during the quarter.
Meridian Wealth Partners sold 403 Bausch Health shares in Q2 2021, an estimated $12K.
Meridian Wealth Partners first reported a position in Bausch Health in Q1 2021 and held it in 1 quarter.
Meridian Wealth Partners's Bausch Health position peaked at $12K in Q1 2021.
357 funds tracked by Wall St. Rank held Bausch Health as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.